Related Experiment Video
Updated: Jan 4, 2026

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
Personalised Medicine Using N-of-1 Trials: Overcoming Barriers to Delivery
Iain Chalmers1, Liam Smeeth2, Ben Goldacre1
1Department of Primary Care, University of Oxford, Oxford OX2 6GG, UK.
Abstract:
In this paper we discuss the value of N-of-1 trials in personalising health care. We describe the challenges faced in implementing N-of-1 trials in the United Kingdom's National Health Service and suggest how making greater use of these personalised trials might be facilitated.
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Dosage Regimen: Individualization
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Microorganisms in Medicine and Therapeutics

